КАРДИОРЕСИНХРОНИЗИРУЮЩАЯ ТЕРАПИЯ И ПРЕДУПРЕЖДЕНИЕ ВНЕЗАПНОЙ СЕРДЕЧНОЙ СМЕРТИ

1. Levy D, Kechaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.

2. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med 1982;307:1051-1058.

3. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.

4. Cleland J, Daubert JC, Erdmann E, et al.Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006; 27:1928-1932.

5. Daubert JC, Leclercq C, Mabo P. There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure. J Am Coll Cardiol 2005;46:2204 -2007.

6. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure. Ann Intern Med 2004;141:381-390.

7. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: part 1 - issues before device implantation; Part 2 - Issues During and After Device Implantation and Unresolved Questions. J Am Coll Cardiol 2005;46:2153- 67.

8. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: part 1 - issues before device implantation; Part 2 - Issues During and After Device Implantation and Unresolved Questions. J Am Coll Cardiol 2005;46: 2168-82.

9. Bristow MR, Saxon LA, Boehmer J, et al., Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.

10. Cleland J, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.

11. Kies P, Bax JJ, Molhoek SG, et al. Effect of cardiac resynchronization therapy on inducibility of ventricular tachyarrhythmias in cardiac arrest survivors with either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005;95:1111-1114.

12. Garrigue S, Barold SS, Hocini M, Jaas P, Hasaguerre M, Clementy J. Treatment of drug refractory ventricular tachycardia by biventricular pacing. Pacing Clin Electrophysiol 2000; 23:1700-1702.

13. Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JG. Clinical trails update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001; 3:491-494.

14. Arya A, HaghjooM, Dehghani MR, et al. Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Heart Rhythm 2005; 2:1094-1098.

15. Befeler B, Berkovits BV, Aranda JM, et al. Programmed simultaneous biventricular stimulation in man, with special reference to its use in the evaluation of intraventricular reentry. Eur J Cardiol 1979; 9:369-378.

16. Daubert JC, Mabo P, Gras D, et al. Dual-site ventricular pacing for prevention of ventricular tachycardia in patients with intraventricular conduction block (abstract) Eur JCPE 1996; 6:134.

17. Higgins SL, Yong P, Sheck D, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy: Ventak CHF Investigators. J Am Coll Cardiol 2000; 36: 824-827.

18. Ermis C, Seutter R, Zhu AX, et al. Impact of Upgrade to Cardiac Resynchronization Therapy on Ventricular Arrhythmia Frequency in Patients With Implantable Cardioverter-Defibrillators. J Am Coll Cardiol 2005;46:2258-2263.

19. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42:1454-1459.

20. Young JB, Abraham WT, Smith AL, et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003; 289:2685-2694.

21. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-740.

22. Ovsyshcher IE, Auricchio A. Cardiac resynchronization therapy for heart failure is showing great promise. IMAJ 2003:5:589-591.

23. Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003; 107: 740-746.

24. Fish JM, Di Diego JM, Nesterenko V, Antzelevitch C. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization. Implications for biventricular pacing. Circulation 2004; 109:2136-2142.

25. Garrigue S, Reuter S, Efimov IR, et al. Optical mapping technique applied to biventricular pacing: potential mechanisms of ventricular arrhythmias occurrence. Pacing Clin Electrophysiol 2003; 26 (1 Pt 2): 197-205.

26. Guerra JM, WU J, Miller JM, et al. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003; 14: 1245-1247

27. Di Cori A, Bongiorni MG, Arena G, et al. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005; 12: 231-235.

28. Turitto G, Haq S, Benson D, El-Sherif N. Torsade De Pointes: An Electrophysiological Effect of Cardiac Resynchronization? Pacing Clin Electrophysiol 2006;29:520-522.

29. Alonso C, Leclercq C, Caseau S, et al. Biventricular pacing has both arrhythmogenic and antiarrhythmic effects: results from MUSTIC study. Eur Hear J Suppl. 2002; 23:527A.

30. Mykytsey A, Maheshwarl P, Dhrar G, et al. Ventricular tachycardia induced by biventricular pacing in patient with severe ischemic cardiomyopahy. J Cardiovasc Electrophysiol 2005; 16:655-658.

31. Shukla G, Chaudhry M, Orlov M, Hoffmeister P, Haffajee C. Potential proarrhythmic effect of biventricular pacing: Fact or myth? Heart Rhythm 2005; 2:951-956.

32. Bortone A, Macia J-C, Leclercq F, PasquiJ-L. Monomorphic Ventricular Tachycardia Induced by Cardiac Resynchronization Therapy in Patient with Severe Nonischemic Dilated Cardiomyopathy. Pacing Clin Electrophysiol 2006; 29: 327-330.

33. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 2003; 108: 704-710.

34. Turitto G, El-SherifN. Cardiac resynchronization therapy: Is it antiarrhythmic or proarrhythmic? In: Raviele A (ed.): Venice Arrhythmias 2005. Springer Verlag, 2005; 519-526.

35. Fish MJ, Brugada J, Antzelevitch C. Potential Proarrhythmic Effects of Biventricular Pacing. J Am Coll Cardiol 2005;46;2340-2347.

36. Carson P, Anand I, O’Connor C, et al. Mode of Death in Advanced Heart Failure The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial. J Am Coll Cardiol 2005;46:2329 -2334.

37. Saxon LA. More is better with cardiac resynchronization therapy-but is it enough? Eur Heart J 2006; 27:18911892.

38. Lindenfeld J, Feldman AM, Saxon L, et al. Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure. Circulation. 2007; 115: 204-212.

39. Adams, KF, Lindenfeld J, Arnold JMO, et al. Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Cardiac Failure 2006;12: 10-38.

40. Moss AJ, Zareba W, Hall WJ, et al. The Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.

41. Bardy GH, Lee KL, Mark DB, et al., The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.

42. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Circulation. 2006;114: 2006 Aug 25; [Epub ahead of print].

43. Ovsyshcher IE, Barold SS. Should Cardiac Resynchronization be Considered For the Primary Prevention of Heart Failure? In: S. Serge Barold and Philippe Ritter, eds. Devices for Cardiac Resynchronization: Technologic and Clinical Aspects. Springer, 2007, Ch. 9.

44. Rivera DA, Bristow MR. Cardiac resynchronization-a heart failure perspective. ANE 2005;10(4) Suppl: 16-23.

45. Ermis C, Lurie K, Zhu A, et al. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2004; 15: 862-866.

46. Pappone C, Augello G, Vicedomini G, et al. Backup defibrillation prolongs survival in patients with indications for CRT by reducing sudden cardiac death (abstr). Circulation 2004; 110: III461.

47. Ypenburg C, Erven L, Bleeker GB, et al. Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias. J Am Coll Cardiol 2006;48: 464-470.

48. Ermis C, Benditt DG. Cardiac resynchronization pacing without defibrillator capability: is this a viable option? Europace 2006 Jul;8(7): 499-501.

49. Gasparini M, Lunati M, Santini M, et al. Long-Term Survival in Patients Treated with Cardiac Resynchronization Therapy: A 3-Year Follow-Up Study from the InSync/ InSync ICD Italian Registry. Pacing Clin Electrophysiol 2006; 29:S2-S10.

50. Rivera-Ayerza M, Theuns DAMJ, Garcia-Garsia HM,, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trails. Eur Heart J 2006; 27(22) November: 2682-2688.

51. Fauchier L, Poret P, Robin I, de Labriolle A, Giraudeau C, Cosnay P, Babuty D. Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2006 Feb 1;97(3): 393-9.

52. Chugh A, Scharf C, Hall B, et al. Prevalence and Management of Inappropriate Detection and Therapies in Patients with First-Generation Biventricular Pacemaker-Defibrillators. Pacing Clin Electrophysiol 2005; 28 (1): 44-50.

53. Lindenfeld J, Feldman AM, Saxon L, et al. Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure. Circulation. 2007;115:204-212.

54. Yao G, Freemantle N, Calvert MG, et al. The longterm cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007; 28, 42-51.

55. Tandri H, Griffith LS, Tang T, et al. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006;3:762-768.

56. Morgan Stanley Equity Research North America. Hospital Supplies & Medical Technology. Industry Overview, March, 2006.